Highly Specialised Technology

Pharma collaborates to improve chances of NICE backing Duchenne drugs

https://pharmaphorum.com/news/pharmas-join-improve-duchenne-muscular-dystrophy/

Budget impact and cost effectiveness: alternatives to NICE and NHSE proposals

https://pharmaphorum.com/views-and-analysis/budget-impact-cost-effectiveness-alternatives-nice-nhse-proposals/

NICE and Highly Specialised Technologies: three years on

https://pharmaphorum.com/views-and-analysis/nice-and-highly-specialised-technologies-three-years-on/

Funding rare disease treatments in the UK – navigating the labyrinth

https://pharmaphorum.com/views-and-analysis/funding-rare-disease-treatments-in-the-uk-navigating-the-labyrinth/

Close in 10 seconds

Pharmaphorum.com

Search